Accumetrics Inc Announces GRAVITAS Trial 50% Enrolled
Accumetrics Inc announces that it has reached the halfway mark (1,600 patients) in the enrollment of its clinical trial, GRAVITAS (Gauging Responsiveness with A VerifyNow Assay Impact on Thrombosis And Safety).
Read More